SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007477
Filing Date
2024-05-09
Accepted
2024-05-09 08:21:14
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20240331x10q.htm   iXBRL 10-Q 1920633
2 EX-31.1 mgtx-20240331xex31d1.htm EX-31.1 11368
3 EX-31.2 mgtx-20240331xex31d2.htm EX-31.2 11318
4 EX-32.1 mgtx-20240331xex32d1.htm EX-32.1 6759
5 EX-32.2 mgtx-20240331xex32d2.htm EX-32.2 6767
  Complete submission text file 0001558370-24-007477.txt   7912346

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20240331.xsd EX-101.SCH 57889
7 EX-101.CAL mgtx-20240331_cal.xml EX-101.CAL 50661
8 EX-101.DEF mgtx-20240331_def.xml EX-101.DEF 241335
9 EX-101.LAB mgtx-20240331_lab.xml EX-101.LAB 439313
10 EX-101.PRE mgtx-20240331_pre.xml EX-101.PRE 386647
75 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20240331x10q_htm.xml XML 1277982
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 24928730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)